Recent YSCC Discoveries

For more than 25 years, innovative research on health conditions specifically affecting women, more prevalent in women, or affecting women differently than men has been at the core of Women’s Health Research at Yale.

Mice that received antibodies from Long COVID patients showed symptoms including pain and dizziness, a Yale-led study has found.

The European Medical Journal (EMJ) interviews Mario Strazzabosco, MD, PhD, about developments in liver cancer treatment, the physician-patient relationship, and new discoveries in cholangiocarcinoma (CCA).

Trainee colloquium at YCC

The antinuclear antibody-drug conjugates (ANADCs) were effective against mouse models of breast cancer and colon cancer, and even improved survival in mouse models of glioma, senior author Dr. James Hansen of Yale Cancer Center said. Efforts are now underway to advance this therapy to testing in the clinical trial setting.

A team at Yale, led by Martin Schwartz, PhD, Robert W. Berliner Professor of Medicine (cardiology), has identified a protein that helps your body sense and respond to changes in this shear stress.

Women’s Health Research at Yale today announced two research awards, one aimed at more effectively treating endometriosis and the second designed to help women who have been incarcerated improve their health outcomes.

The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases. In addition to grant funding, Colton Center awardees receive mentorship, access to industry expertise, and feedback on their potential commercialization.

To better understand the impact of NIH funding, U.S. Sen. Richard Blumenthal visited Yale School of Medicine for a tour of neuroscience lab facilities and a discussion with neuroscience researchers.